Antileishmanial activity of antimonials entrapped in liposomes.
about
Pentavalent antimonials: new perspectives for old drugsTherapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c miceLiposome formulations with prolonged circulation time in blood and enhanced uptake by tumorsAntileishmanial activities of stearylamine-bearing liposomesAssociation of liposome-encapsulated trivalent antimonial with ascorbic acid: an effective and safe strategy in the treatment of experimental visceral leishmaniasis.In vitro lysis of the bloodstream forms of Trypanosoma brucei gambiense by stearylamine-bearing liposomesAntileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeysAntisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis.Treatment of experimental cutaneous leishmaniasis with liposome-intercalated amphotericin B.Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study.Development of new derivatives of primaquine by association with lysosomotropic carriers.Antileishmanial drug targeting through glycosylated polymers specifically internalized by macrophage membrane lectins.Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.Drug delivery strategies for therapy of visceral leishmaniasis.Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasisNew delivery strategies for the old pentavalent antimonial drugs.Drug resistance in leishmaniasis: current drug-delivery systems and future perspectives.Neglected tropical diseases: now more than just 'other diseases'--the post-2015 agenda.Application of liposomes in medicine and drug delivery.Drug delivery systems. 1. site-specific drug delivery using liposomes as carriers.Preparation and use of liposomes in the treatment of microbial infections.Liposomes as carriers of antimicrobial agentsTargeting of liposomes to tumor cells in vivo.Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes.Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.Nanostructured delivery systems with improved leishmanicidal activity: a critical review.The chemotherapy of protozoal infections: whither?Liposomes in the treatment of infections.The past, present, and future uses of liposomes in treating infectious diseases.Liposome: classification, preparation, and applications.Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.Uptake and intracellular processing of targeted and nontargeted liposomes by rat Kupffer cells in vivo and in vitro.The six diseases of WHO. LeishmaniasisSynthesis of antimony complexes of yeast mannan and mannan derivatives and their effect on Leishmania-infected macrophages.Development of liposomes loaded with anti-leishmanial drugs for the treatment of cutaneous leishmaniasis.Targeting of mannosylated liposome incorporated benzyl derivative of Penicillium nigricans derived compound MT81 to reticuloendothelial systems for the treatment of visceral leishmaniasis.
P2860
Q28253055-A7F29313-ADF2-46AD-B63E-D63BAAFB3EA9Q28477398-600B0C33-E017-487C-A15E-3BAFCC6A59AFQ33649082-376A4231-AF99-407D-9F4D-44BA6AC940B0Q33979887-C36FDAB6-FE5E-439C-B34B-1CCFF89E099AQ34020450-EEEFD26A-C14D-4B9C-B50D-DB814AE05820Q35311986-20C3E427-EADC-4218-AF95-2F72634703B7Q35653579-7864D48B-32ED-46DF-B18C-2268316B64FCQ35668979-A6218584-D8C4-4868-AB58-0A4EE5759A9DQ35760259-1F55946A-52FD-4EB4-B6FB-4CF6964EA8AAQ36397370-91AE5751-B171-4171-95A8-F3BDD2298CE9Q36675517-52BE3B08-F69C-4896-9976-A6F8834143BCQ36757841-B4DD0F96-0B7A-4C56-83CB-FF7DE0702AD3Q37589185-66815F61-317F-4659-8441-4C5CA349D673Q37702257-700CDDB2-2C81-4A06-BAC3-35086891CEBEQ37722715-00685A10-3105-4449-9F32-93C92A487688Q37804399-E6F5BB01-BF6A-4BB6-A390-344E40C35B32Q38154347-DF4D32B6-5D6C-4661-9D37-7981B6A0B93EQ38223613-AF4975C0-AAE6-4578-BAB5-F5DC99FB6B6DQ38249220-94205F59-B035-424E-A60A-363AB4A8D2C8Q38689437-64C65450-7736-4817-AE6B-6558E67365AEQ39654122-F71F1B40-BA4A-4059-BAAD-47EC869F66DDQ39661451-B58A4180-B027-4506-818A-C2614B25C615Q39696588-05626AEA-AD1C-46CB-9029-EE762C17248AQ39834052-DD18A486-AD36-4883-B20C-37F62D7329FEQ39955167-6F1B4A40-E0F6-4A23-BAA5-64ACFEC5B791Q40099567-9D9EAA2D-21FF-4598-8E21-B22090BBE2CDQ40125390-4FA52918-9F35-4464-AF43-2A48BB800516Q40499095-0736755A-FD02-4CCF-B98B-63D1571B14B4Q40530985-A0C0E09C-67E5-4926-B457-D469D1E459ACQ41049173-DC52A9EC-2673-4605-B480-965D8E92C07EQ41678461-4CD69E45-7CEA-4ED4-8E74-45553A6E2457Q41918026-8A173D2F-7BD2-42C9-BE5B-5EB18D99C3A6Q42357040-7F244947-FF10-4A8F-A59E-761E97B14A78Q42796451-3B3A9352-2C09-43CA-A351-6474673F3B21Q44058897-25CD807B-92F8-43A9-BD9D-7DDCECBDC115Q46731824-F049EBD1-89D4-4FD7-8C26-0A1CC0BA6E50
P2860
Antileishmanial activity of antimonials entrapped in liposomes.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Antileishmanial activity of antimonials entrapped in liposomes.
@en
type
label
Antileishmanial activity of antimonials entrapped in liposomes.
@en
prefLabel
Antileishmanial activity of antimonials entrapped in liposomes.
@en
P2093
P356
P1433
P1476
Antileishmanial activity of antimonials entrapped in liposomes.
@en
P2093
P2860
P2888
P356
10.1038/272055A0
P407
P577
1978-03-01T00:00:00Z
P6179
1035832979